• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

EWSR1-FLI1活性的细胞间异质性决定了尤因肉瘤细胞的增殖/迁移选择。

Cell-to-cell heterogeneity of EWSR1-FLI1 activity determines proliferation/migration choices in Ewing sarcoma cells.

作者信息

Franzetti G-A, Laud-Duval K, van der Ent W, Brisac A, Irondelle M, Aubert S, Dirksen U, Bouvier C, de Pinieux G, Snaar-Jagalska E, Chavrier P, Delattre O

机构信息

Institut Curie, PSL Research University, Paris cedex 05, France.

INSERM U830, Genetic and Biology of Pediatric Tumors group, Institut Curie Research Center, Paris, France.

出版信息

Oncogene. 2017 Jun 22;36(25):3505-3514. doi: 10.1038/onc.2016.498. Epub 2017 Jan 30.

DOI:10.1038/onc.2016.498
PMID:28135250
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5541267/
Abstract

Ewing sarcoma is characterized by the expression of the chimeric EWSR1-FLI1 transcription factor. Proteomic analyses indicate that the decrease of EWSR1-FLI1 expression leads to major changes in effectors of the dynamics of the actin cytoskeleton and the adhesion processes with a shift from cell-to-cell to cell-matrix adhesion. These changes are associated with a dramatic increase of in vivo cell migration and invasion potential. Importantly, EWSR1-FLI1 expression, evaluated by single-cell RT-ddPCR/immunofluorescence analyses, and activity, assessed by expression of EWSR1-FLI1 downstream targets, are heterogeneous in cell lines and in tumours and can fluctuate along time in a fully reversible process between EWSR1-FLI1 states, characterized by highly active cell proliferation, and EWSR1-FLI1 states where cells have a strong propensity to migrate, invade and metastasize. This new model of phenotypic plasticity proposes that the dynamic fluctuation of the expression level of a dominant oncogene is an intrinsic characteristic of its oncogenic potential.

摘要

尤因肉瘤的特征是嵌合型EWSR1-FLI1转录因子的表达。蛋白质组学分析表明,EWSR1-FLI1表达的降低会导致肌动蛋白细胞骨架动力学效应器以及黏附过程发生重大变化,从细胞间黏附转变为细胞与基质黏附。这些变化与体内细胞迁移和侵袭潜能的显著增加有关。重要的是,通过单细胞RT-ddPCR/免疫荧光分析评估的EWSR1-FLI1表达以及通过EWSR1-FLI1下游靶点表达评估的活性,在细胞系和肿瘤中是异质的,并且在以高活性细胞增殖为特征的EWSR1-FLI1状态与细胞具有强烈迁移、侵袭和转移倾向的EWSR1-FLI1状态之间的完全可逆过程中,会随时间波动。这种新的表型可塑性模型表明,显性癌基因表达水平的动态波动是其致癌潜能的内在特征。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54d5/5541267/24dc16925905/onc2016498f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54d5/5541267/4bba6891389e/onc2016498f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54d5/5541267/f0dd179a53ba/onc2016498f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54d5/5541267/3f799cc5f41b/onc2016498f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54d5/5541267/94daa0becea7/onc2016498f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54d5/5541267/24dc16925905/onc2016498f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54d5/5541267/4bba6891389e/onc2016498f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54d5/5541267/f0dd179a53ba/onc2016498f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54d5/5541267/3f799cc5f41b/onc2016498f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54d5/5541267/94daa0becea7/onc2016498f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54d5/5541267/24dc16925905/onc2016498f5.jpg

相似文献

1
Cell-to-cell heterogeneity of EWSR1-FLI1 activity determines proliferation/migration choices in Ewing sarcoma cells.EWSR1-FLI1活性的细胞间异质性决定了尤因肉瘤细胞的增殖/迁移选择。
Oncogene. 2017 Jun 22;36(25):3505-3514. doi: 10.1038/onc.2016.498. Epub 2017 Jan 30.
2
Ewing sarcoma fusion protein EWSR1/FLI1 interacts with EWSR1 leading to mitotic defects in zebrafish embryos and human cell lines.尤因肉瘤融合蛋白EWSR1/FLI1与EWSR1相互作用,导致斑马鱼胚胎和人类细胞系出现有丝分裂缺陷。
Cancer Res. 2009 May 15;69(10):4363-71. doi: 10.1158/0008-5472.CAN-08-3229. Epub 2009 May 5.
3
Chimeric EWSR1-FLI1 regulates the Ewing sarcoma susceptibility gene EGR2 via a GGAA microsatellite.嵌合蛋白EWSR1-FLI1通过GGAA微卫星调控尤文肉瘤易感基因EGR2。
Nat Genet. 2015 Sep;47(9):1073-8. doi: 10.1038/ng.3363. Epub 2015 Jul 27.
4
Long noncoding RNA EWSAT1-mediated gene repression facilitates Ewing sarcoma oncogenesis.长链非编码RNA EWSAT1介导的基因抑制促进尤因肉瘤的肿瘤发生。
J Clin Invest. 2014 Dec;124(12):5275-90. doi: 10.1172/JCI72124. Epub 2014 Nov 17.
5
Targeting the EWSR1-FLI1 oncogene-induced protein kinase PKC-β abolishes ewing sarcoma growth.靶向 EWSR1-FLI1 癌基因诱导的蛋白激酶 PKC-β 可抑制尤文肉瘤生长。
Cancer Res. 2012 Sep 1;72(17):4494-503. doi: 10.1158/0008-5472.CAN-12-0371. Epub 2012 Aug 28.
6
ETS1, a Target Gene of the EWSR1::FLI1 Fusion Oncoprotein, Regulates the Expression of the Focal Adhesion Protein TENSIN3.ETS1 是 EWSR1::FLI1 融合癌蛋白的靶基因,调节黏着斑蛋白 TENSIN3 的表达。
Mol Cancer Res. 2024 Jul 2;22(7):625-641. doi: 10.1158/1541-7786.MCR-23-1090.
7
Selective inhibition of HDAC6 regulates expression of the oncogenic driver EWSR1-FLI1 through the EWSR1 promoter in Ewing sarcoma.选择性抑制 HDAC6 通过 EWSR1 启动子调控尤文肉瘤中致癌驱动基因 EWSR1-FLI1 的表达。
Oncogene. 2021 Sep;40(39):5843-5853. doi: 10.1038/s41388-021-01974-4. Epub 2021 Aug 3.
8
CD44 Modulates Cell Migration and Invasion in Ewing Sarcoma Cells.CD44 调节尤文肉瘤细胞的迁移和侵袭。
Int J Mol Sci. 2023 Jul 21;24(14):11774. doi: 10.3390/ijms241411774.
9
Characterization of human mesenchymal stem cells from ewing sarcoma patients. Pathogenetic implications.尤因肉瘤患者人间充质干细胞的特征。发病机制探讨。
PLoS One. 2014 Feb 3;9(2):e85814. doi: 10.1371/journal.pone.0085814. eCollection 2014.
10
Therapeutic targeting the oncogenic driver EWSR1::FLI1 in Ewing sarcoma through inhibition of the FACT complex.通过抑制FACT复合物对尤因肉瘤中的致癌驱动因子EWSR1::FLI1进行治疗靶向。
Oncogene. 2023 Jan;42(1):11-25. doi: 10.1038/s41388-022-02533-1. Epub 2022 Nov 10.

引用本文的文献

1
TGFβ Inhibition during Radiotherapy Enhances Immune Cell Infiltration and Decreases Metastases in Ewing Sarcoma.放疗期间抑制转化生长因子β可增强尤因肉瘤中的免疫细胞浸润并减少转移。
Cancer Res Commun. 2025 Aug 1;5(8):1441-1457. doi: 10.1158/2767-9764.CRC-24-0346. Epub 2025 Aug 8.
2
Targeted CRISPR approach reveals an essential role for neuropeptide Y receptor Y5 in Ewing sarcoma extrapulmonary metastasis.靶向CRISPR方法揭示了神经肽Y受体Y5在尤因肉瘤肺外转移中的关键作用。
Oncogene. 2025 Jul 17. doi: 10.1038/s41388-025-03493-y.
3
Subversion of mRNA degradation pathways by EWSR1::FLI1 represents a therapeutic vulnerability in Ewing sarcoma.

本文引用的文献

1
The hypoxic cancer secretome induces pre-metastatic bone lesions through lysyl oxidase.缺氧癌细胞分泌组通过赖氨酰氧化酶诱导骨转移前病变。
Nature. 2015 Jun 4;522(7554):106-110. doi: 10.1038/nature14492. Epub 2015 May 27.
2
Translational Activation of HIF1α by YB-1 Promotes Sarcoma Metastasis.YB-1 促进 HIF1α 的翻译激活从而促进肉瘤转移。
Cancer Cell. 2015 May 11;27(5):682-97. doi: 10.1016/j.ccell.2015.04.003.
3
Sarcomas.肉瘤
EWSR1::FLI1对mRNA降解途径的破坏是尤因肉瘤的一个治疗弱点。
Nat Commun. 2025 Jul 16;16(1):6537. doi: 10.1038/s41467-025-61725-x.
4
Autocrine TGFβ2 enforces a transcriptionally hybrid cell state in Ewing sarcoma.自分泌转化生长因子β2(TGFβ2)在尤因肉瘤中维持一种转录混合细胞状态。
bioRxiv. 2025 Jun 12:2025.06.11.653876. doi: 10.1101/2025.06.11.653876.
5
Different neutrophil extracellular trap related Ewing sarcoma subtypes exhibit distinct prognosis, and immune microenvironment characteristics.不同的中性粒细胞胞外诱捕网相关尤文肉瘤亚型表现出不同的预后和免疫微环境特征。
Sci Rep. 2025 Jul 8;15(1):24523. doi: 10.1038/s41598-025-10277-7.
6
Rhabdomyosarcoma fusion oncoprotein initially pioneers a neural signature in vivo.横纹肌肉瘤融合癌蛋白最初在体内开创了一种神经特征。
Cell Rep. 2025 Jul 22;44(7):115923. doi: 10.1016/j.celrep.2025.115923. Epub 2025 Jul 3.
7
Fusion genes in cancers: Biogenesis, functions, and therapeutic implications.癌症中的融合基因:生物发生、功能及治疗意义
Genes Dis. 2025 Jan 20;12(5):101536. doi: 10.1016/j.gendis.2025.101536. eCollection 2025 Sep.
8
Robust statistical assessment of Oncogenotype to Organotropism translation in xenografted zebrafish.对异种移植斑马鱼中癌基因分型向器官嗜性转化的稳健统计评估。
bioRxiv. 2025 Jun 1:2025.05.28.656734. doi: 10.1101/2025.05.28.656734.
9
Targeting metastasis in paediatric bone sarcomas.靶向治疗小儿骨肉瘤的转移
Mol Cancer. 2025 May 29;24(1):153. doi: 10.1186/s12943-025-02365-z.
10
High Tau expression correlates with reduced invasion and prolonged survival in Ewing sarcoma.高 Tau 蛋白表达与尤因肉瘤侵袭性降低及生存期延长相关。
Cell Death Discov. 2025 May 3;11(1):216. doi: 10.1038/s41420-025-02497-7.
Pediatr Clin North Am. 2015 Feb;62(1):179-200. doi: 10.1016/j.pcl.2014.09.012.
4
Suppression of deacetylase SIRT1 mediates tumor-suppressive NOTCH response and offers a novel treatment option in metastatic Ewing sarcoma.抑制去乙酰化酶 SIRT1 介导肿瘤抑制性 NOTCH 反应,并为转移性尤文肉瘤提供新的治疗选择。
Cancer Res. 2014 Nov 15;74(22):6578-88. doi: 10.1158/0008-5472.CAN-14-1736. Epub 2014 Oct 3.
5
Genomic landscape of Ewing sarcoma defines an aggressive subtype with co-association of STAG2 and TP53 mutations.尤因肉瘤的基因组图谱定义了一种具有STAG2和TP53突变共同关联的侵袭性亚型。
Cancer Discov. 2014 Nov;4(11):1342-53. doi: 10.1158/2159-8290.CD-14-0622. Epub 2014 Sep 15.
6
The genomic landscape of pediatric Ewing sarcoma.儿童尤文肉瘤的基因组景观。
Cancer Discov. 2014 Nov;4(11):1326-41. doi: 10.1158/2159-8290.CD-13-1037. Epub 2014 Sep 3.
7
Molecular dissection of the mechanism by which EWS/FLI expression compromises actin cytoskeletal integrity and cell adhesion in Ewing sarcoma.对尤因肉瘤中EWS/FLI表达损害肌动蛋白细胞骨架完整性和细胞黏附的机制进行分子剖析。
Mol Biol Cell. 2014 Sep 15;25(18):2695-709. doi: 10.1091/mbc.E14-01-0007. Epub 2014 Jul 23.
8
The genomic landscape of the Ewing Sarcoma family of tumors reveals recurrent STAG2 mutation.尤因肉瘤家族性肿瘤的基因组图谱显示出复发性STAG2突变。
PLoS Genet. 2014 Jul 10;10(7):e1004475. doi: 10.1371/journal.pgen.1004475. eCollection 2014 Jul.
9
Cyclophosphamide compared with ifosfamide in consolidation treatment of standard-risk Ewing sarcoma: results of the randomized noninferiority Euro-EWING99-R1 trial.环磷酰胺与异环磷酰胺在标准风险尤文肉瘤巩固治疗中的比较:随机非劣效性 Euro-EWING99-R1 试验结果。
J Clin Oncol. 2014 Aug 10;32(23):2440-8. doi: 10.1200/JCO.2013.54.4833. Epub 2014 Jun 30.
10
Ewing sarcoma inhibition by disruption of EWSR1-FLI1 transcriptional activity and reactivation of p53.破坏 EWSR1-FLI1 转录活性和重新激活 p53 抑制尤因肉瘤。
J Pathol. 2014 Aug;233(4):415-24. doi: 10.1002/path.4378. Epub 2014 Jun 27.